Vespa crabro chromosome 13, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342412.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X3
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha homolog
formin-like protein, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
formin-like protein, transcript variant X1
formin-like protein, transcript variant X4
formin-like protein, transcript variant X3
ADP-ribosylation factor-like protein 4C, transcript variant X3
ADP-ribosylation factor-like protein 4C, transcript variant X1
ADP-ribosylation factor-like protein 4C, transcript variant X2
28 kDa heat- and acid-stable phosphoprotein-like, transcript variant X4
28 kDa heat- and acid-stable phosphoprotein-like, transcript variant X2
28 kDa heat- and acid-stable phosphoprotein-like, transcript variant X3
28 kDa heat- and acid-stable phosphoprotein-like, transcript variant X1
28 kDa heat- and acid-stable phosphoprotein-like
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial, transcript variant X4
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial, transcript variant X3
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial, transcript variant X2
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial, transcript variant X1
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial, transcript variant X5
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial isoform X3
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial isoform X2
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial isoform X1
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial isoform X4
mediator of RNA polymerase II transcription subunit 25-like, transcript variant X3
mediator of RNA polymerase II transcription subunit 25-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 25-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 25-like isoform X3
mediator of RNA polymerase II transcription subunit 25-like isoform X2
mediator of RNA polymerase II transcription subunit 25-like isoform X1
spermatogenesis-defective protein 39 homolog
RNA polymerase II subunit A C-terminal domain phosphatase, transcript variant X3
RNA polymerase II subunit A C-terminal domain phosphatase, transcript variant X1
RNA polymerase II subunit A C-terminal domain phosphatase, transcript variant X2
RNA polymerase II subunit A C-terminal domain phosphatase isoform X1
RNA polymerase II subunit A C-terminal domain phosphatase, transcript variant X4
RNA polymerase II subunit A C-terminal domain phosphatase isoform X2
28S ribosomal protein S17, mitochondrial
probable glutamate receptor, transcript variant X1
probable glutamate receptor, transcript variant X2
probable glutamate receptor, transcript variant X3
probable glutamate receptor, transcript variant X4
probable glutamate receptor, transcript variant X5
probable glutamate receptor, transcript variant X6
uncharacterized LOC124428815, transcript variant X2
uncharacterized LOC124428815, transcript variant X3
uncharacterized LOC124428815, transcript variant X1
uncharacterized protein LOC124428815 isoform X1
uncharacterized protein LOC124428815 isoform X3
uncharacterized protein LOC124428815 isoform X2
cilia- and flagella-associated protein 43-like
uncharacterized LOC124428664, transcript variant X2
uncharacterized LOC124428664, transcript variant X1
uncharacterized LOC124428664, transcript variant X3
uncharacterized LOC124428664, transcript variant X4
uncharacterized protein LOC124428664 isoform X1
uncharacterized protein LOC124428664 isoform X2
carboxypeptidase N subunit 2-like, transcript variant X1
carboxypeptidase N subunit 2-like, transcript variant X2
carboxypeptidase N subunit 2-like, transcript variant X3
carboxypeptidase N subunit 2-like isoform X1
carboxypeptidase N subunit 2-like isoform X2
carboxypeptidase N subunit 2-like isoform X3
uncharacterized LOC124428665, transcript variant X12
uncharacterized LOC124428665, transcript variant X13
uncharacterized protein LOC124428665 isoform X2
uncharacterized protein LOC124428665 isoform X3
uncharacterized LOC124428665, transcript variant X10
uncharacterized LOC124428665, transcript variant X9
uncharacterized LOC124428665, transcript variant X1
uncharacterized LOC124428665, transcript variant X3
uncharacterized LOC124428665, transcript variant X4
uncharacterized LOC124428665, transcript variant X2
uncharacterized LOC124428665, transcript variant X5
uncharacterized LOC124428665, transcript variant X6
uncharacterized LOC124428665, transcript variant X11
uncharacterized LOC124428665, transcript variant X7
uncharacterized LOC124428665, transcript variant X8
uncharacterized protein LOC124428665 isoform X1
cysteine and histidine-rich protein 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
calcium-independent phospholipase A2-gamma-like, transcript variant X1
calcium-independent phospholipase A2-gamma-like, transcript variant X3
calcium-independent phospholipase A2-gamma-like isoform X1
calcium-independent phospholipase A2-gamma-like isoform X3
calcium-independent phospholipase A2-gamma-like, transcript variant X2
calcium-independent phospholipase A2-gamma-like, transcript variant X4
calcium-independent phospholipase A2-gamma-like isoform X2
calcium-independent phospholipase A2-gamma-like isoform X4
atrial natriuretic peptide receptor 1-like, transcript variant X2
atrial natriuretic peptide receptor 1-like, transcript variant X7
atrial natriuretic peptide receptor 1-like isoform X2
atrial natriuretic peptide receptor 1-like, transcript variant X1
atrial natriuretic peptide receptor 1-like, transcript variant X4
atrial natriuretic peptide receptor 1-like isoform X1
atrial natriuretic peptide receptor 1-like isoform X4
atrial natriuretic peptide receptor 1-like, transcript variant X3
atrial natriuretic peptide receptor 1-like, transcript variant X6
atrial natriuretic peptide receptor 1-like isoform X3
atrial natriuretic peptide receptor 1-like isoform X6
atrial natriuretic peptide receptor 1-like, transcript variant X5
atrial natriuretic peptide receptor 1-like isoform X5
uncharacterized LOC124428667, transcript variant X2
uncharacterized LOC124428667, transcript variant X1
uncharacterized protein LOC124428667 isoform X1
uncharacterized protein LOC124428667 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cysteine sulfinic acid decarboxylase, transcript variant X4
cysteine sulfinic acid decarboxylase, transcript variant X1
cysteine sulfinic acid decarboxylase, transcript variant X3
cysteine sulfinic acid decarboxylase, transcript variant X2
centromere protein L-like, transcript variant X2
centromere protein L-like, transcript variant X1
centromere protein L-like, transcript variant X3
growth hormone secretagogue receptor type 1-like, transcript variant X1
growth hormone secretagogue receptor type 1-like, transcript variant X2
growth hormone secretagogue receptor type 1-like, transcript variant X3
growth hormone secretagogue receptor type 1-like, transcript variant X4
growth hormone secretagogue receptor type 1-like isoform X1
growth hormone secretagogue receptor type 1-like isoform X2
growth hormone secretagogue receptor type 1-like isoform X3
growth hormone secretagogue receptor type 1-like isoform X4
uncharacterized LOC124428561, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC124428561, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124428759, transcript variant X1
uncharacterized LOC124428759, transcript variant X2
uncharacterized LOC124428759, transcript variant X3
uncharacterized protein LOC124428759 isoform X3
uncharacterized protein LOC124428759 isoform X1
uncharacterized protein LOC124428759 isoform X2
uncharacterized LOC124428759, transcript variant X7
uncharacterized LOC124428759, transcript variant X4
uncharacterized LOC124428759, transcript variant X6
uncharacterized LOC124428759, transcript variant X5
uncharacterized protein LOC124428759 isoform X4
uncharacterized protein LOC124428759 isoform X5
uncharacterized protein LOC124428759 isoform X6
regulator of G-protein signaling loco, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
regulator of G-protein signaling loco, transcript variant X2
regulator of G-protein signaling loco, transcript variant X1
regulator of G-protein signaling loco isoform X1
regulator of G-protein signaling loco isoform X2
regulator of G-protein signaling loco isoform X3
M-phase inducer phosphatase-like, transcript variant X1
M-phase inducer phosphatase-like, transcript variant X2
M-phase inducer phosphatase-like, transcript variant X4
M-phase inducer phosphatase-like, transcript variant X3
M-phase inducer phosphatase-like, transcript variant X5
M-phase inducer phosphatase-like isoform X1
M-phase inducer phosphatase-like, transcript variant X7
M-phase inducer phosphatase-like, transcript variant X8
M-phase inducer phosphatase-like, transcript variant X9
M-phase inducer phosphatase-like, transcript variant X6
M-phase inducer phosphatase-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
guanine nucleotide exchange factor DBS-like, transcript variant X1
guanine nucleotide exchange factor DBS-like, transcript variant X2
guanine nucleotide exchange factor DBS-like, transcript variant X3
guanine nucleotide exchange factor DBS-like isoform X1
guanine nucleotide exchange factor DBS-like isoform X2
guanine nucleotide exchange factor DBS-like isoform X3
general transcriptional corepressor trfA, transcript variant X4
general transcriptional corepressor trfA, transcript variant X3
general transcriptional corepressor trfA, transcript variant X2
general transcriptional corepressor trfA, transcript variant X1
general transcriptional corepressor trfA, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
general transcriptional corepressor trfA, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
general transcriptional corepressor trfA, transcript variant X5
general transcriptional corepressor trfA, transcript variant X6
general transcriptional corepressor trfA isoform X1
uncharacterized protein DDB_G0284459 isoform X4
general transcriptional corepressor trfA isoform X2
transcription elongation factor SPT5-like
uncharacterized LOC124428636, transcript variant X2
uncharacterized LOC124428636, transcript variant X1
uncharacterized protein LOC124428636 isoform X2
uncharacterized protein LOC124428636 isoform X1
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X2
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X1
tyrosine-protein kinase transmembrane receptor Ror isoform X1
uncharacterized LOC124428635, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124428635, transcript variant X2
uncharacterized LOC124428635, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124428635, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124428635, transcript variant X3
uncharacterized LOC124428635, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124428635, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124428635, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC124428635 isoform X1
uncharacterized protein LOC124428635 isoform X2
uncharacterized protein LOC124428635 isoform X4
uncharacterized protein LOC124428635 isoform X3
tyrosine-protein kinase transmembrane receptor Ror isoform X2
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X3
tyrosine-protein kinase transmembrane receptor Ror isoform X3
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X5
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X4
tyrosine-protein kinase transmembrane receptor Ror isoform X4
tyrosine-protein kinase transmembrane receptor Ror isoform X5
glutamate receptor ionotropic, kainate glr-3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124428674, transcript variant X8
uncharacterized LOC124428674, transcript variant X5
uncharacterized LOC124428674, transcript variant X3
uncharacterized LOC124428674, transcript variant X7
uncharacterized LOC124428674, transcript variant X2
uncharacterized LOC124428674, transcript variant X1
uncharacterized LOC124428674, transcript variant X6
uncharacterized LOC124428674, transcript variant X4
uncharacterized protein LOC124428674 isoform X5
uncharacterized protein LOC124428674 isoform X2
uncharacterized protein LOC124428674 isoform X1
uncharacterized protein LOC124428674 isoform X6
uncharacterized protein LOC124428674 isoform X4
uncharacterized protein LOC124428674 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC124428606, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124428606, transcript variant X2
uncharacterized protein LOC124428606 isoform X1
uncharacterized protein LOC124428606 isoform X2
synaptic vesicular amine transporter, transcript variant X6
synaptic vesicular amine transporter, transcript variant X3
synaptic vesicular amine transporter, transcript variant X7
synaptic vesicular amine transporter, transcript variant X4
synaptic vesicular amine transporter, transcript variant X8
synaptic vesicular amine transporter, transcript variant X5
synaptic vesicular amine transporter, transcript variant X2
synaptic vesicular amine transporter, transcript variant X1
synaptic vesicular amine transporter isoform X1
synaptic vesicular amine transporter isoform X2
synaptic vesicular amine transporter isoform X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X4
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X7
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X10
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X13
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X6
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X11
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X8
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X14
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X3
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X9
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X5
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X12
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X17
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X16
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X1
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X15
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X1
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X5
uncharacterized protein LOC124428849 isoform X6
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X3
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X4
uncharacterized LOC124428854, transcript variant X1
uncharacterized LOC124428854, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger CCCH domain-containing protein 14
WD repeat-containing protein 35, transcript variant X2
WD repeat-containing protein 35, transcript variant X1
zinc transporter 2-like, transcript variant X4
zinc transporter 2-like, transcript variant X3
zinc transporter 2-like, transcript variant X1
zinc transporter 2-like, transcript variant X2
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X2
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X3
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X6
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X5
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X1
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X4
UDP-glucose:glycoprotein glucosyltransferase isoform X2
UDP-glucose:glycoprotein glucosyltransferase isoform X1
mediator of RNA polymerase II transcription subunit 15-like
general odorant-binding protein 83a-like, transcript variant X3
general odorant-binding protein 83a-like, transcript variant X2
general odorant-binding protein 83a-like, transcript variant X1
general odorant-binding protein 83a-like isoform X1
general odorant-binding protein 69a-like isoform X2
general odorant-binding protein 83a-like isoform X3
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124428756
CXXC motif containing zinc binding protein
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124428752, transcript variant X2
uncharacterized LOC124428752, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC124428752 isoform X2
uncharacterized protein LOC124428752 isoform X1
uncharacterized LOC124428727, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124428727, transcript variant X3
uncharacterized LOC124428727, transcript variant X1
ribosomal RNA processing protein 36 homolog
sodium/potassium-transporting ATPase subunit alpha, transcript variant X3
sodium/potassium-transporting ATPase subunit alpha, transcript variant X2
sodium/potassium-transporting ATPase subunit alpha, transcript variant X5
sodium/potassium-transporting ATPase subunit alpha, transcript variant X1
sodium/potassium-transporting ATPase subunit alpha, transcript variant X6
sodium/potassium-transporting ATPase subunit alpha, transcript variant X4
sodium/potassium-transporting ATPase subunit alpha isoform X5
sodium/potassium-transporting ATPase subunit alpha isoform X2
sodium/potassium-transporting ATPase subunit alpha isoform X1
sodium/potassium-transporting ATPase subunit alpha isoform X3
sodium/potassium-transporting ATPase subunit alpha isoform X6
sodium/potassium-transporting ATPase subunit alpha isoform X4
NPC intracellular cholesterol transporter 2 homolog a-like
estradiol 17-beta-dehydrogenase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
estradiol 17-beta-dehydrogenase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
estradiol 17-beta-dehydrogenase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
estradiol 17-beta-dehydrogenase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
39S ribosomal protein S18a, mitochondrial
ribosome-releasing factor 2, mitochondrial
ribosomal protein VAR1, mitochondrial-like
transcription factor kayak, transcript variant X2
transcription factor kayak, transcript variant X1
transcription factor kayak, transcript variant X3
transcription factor kayak, transcript variant X4
uncharacterized LOC124428743, transcript variant X1
uncharacterized LOC124428743, transcript variant X2
p53 and DNA damage-regulated protein 1, transcript variant X3
p53 and DNA damage-regulated protein 1, transcript variant X4
p53 and DNA damage-regulated protein 1, transcript variant X2
p53 and DNA damage-regulated protein 1, transcript variant X1
hairy/enhancer-of-split related with YRPW motif protein-like
facilitated trehalose transporter Tret1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 22% coverage of the annotated genomic feature by RNAseq alignments
octopamine receptor beta-2R, transcript variant X6
octopamine receptor beta-2R, transcript variant X7
octopamine receptor beta-2R, transcript variant X8
octopamine receptor beta-2R, transcript variant X13
octopamine receptor beta-2R, transcript variant X9
octopamine receptor beta-2R, transcript variant X15
octopamine receptor beta-2R, transcript variant X10
octopamine receptor beta-2R, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
octopamine receptor beta-2R, transcript variant X12
octopamine receptor beta-2R, transcript variant X11
octopamine receptor beta-2R, transcript variant X4
octopamine receptor beta-2R, transcript variant X3
octopamine receptor beta-2R, transcript variant X5
octopamine receptor beta-2R, transcript variant X1
octopamine receptor beta-2R, transcript variant X2
immunoglobulin-binding protein 1, transcript variant X2
immunoglobulin-binding protein 1, transcript variant X1
immunoglobulin-binding protein 1 isoform X1
immunoglobulin-binding protein 1 isoform X2
polypeptide N-acetylgalactosaminyltransferase 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 3-like, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 3-like, transcript variant X5
polypeptide N-acetylgalactosaminyltransferase 3-like, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 3-like isoform X1
polypeptide N-acetylgalactosaminyltransferase 3-like isoform X3
polypeptide N-acetylgalactosaminyltransferase 3-like isoform X2
Krueppel-like factor luna, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Krueppel-like factor luna, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC124428624, transcript variant X1
uncharacterized LOC124428624, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
histone-lysine N-methyltransferase PRDM16-like, transcript variant X3
transcription factor hamlet-like isoform X3
histone-lysine N-methyltransferase PRDM16-like, transcript variant X1
histone-lysine N-methyltransferase PRDM16-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
histone-lysine N-methyltransferase PRDM16-like isoform X1
histone-lysine N-methyltransferase PRDM16-like isoform X2
uncharacterized LOC124428795, transcript variant X1
uncharacterized LOC124428795, transcript variant X2
uncharacterized protein LOC124428794 isoform X1
uncharacterized protein LOC124428794 isoform X2
uncharacterized protein LOC124428794 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ribonuclease P protein subunit p38-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ribonuclease P protein subunit p38-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ribonuclease P protein subunit p38-like isoform X1
ribonuclease P protein subunit p38-like isoform X2
mitochondrial uncoupling protein Bmcp, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
mitochondrial uncoupling protein Bmcp, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mitochondrial uncoupling protein Bmcp, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein C18orf63-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C18orf63-like, transcript variant X1
uncharacterized protein C18orf63-like, transcript variant X2
transcriptional regulator Kaiso-like isoform X7
uncharacterized protein C18orf63-like isoform X1
uncharacterized protein C18orf63-like isoform X2
uncharacterized protein C18orf63-like, transcript variant X3
uncharacterized protein LOC124428524 isoform X3
uncharacterized protein C18orf63-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein C18orf63-like, transcript variant X4
uncharacterized protein C18orf63-like, transcript variant X5
protein tramtrack, beta isoform-like isoform X6
protein tramtrack, beta isoform-like isoform X4
uncharacterized LOC124428526, transcript variant X1
uncharacterized LOC124428526, transcript variant X3
uncharacterized LOC124428526, transcript variant X2
uncharacterized LOC124428893, transcript variant X1
uncharacterized LOC124428893, transcript variant X2
uncharacterized protein LOC124428893 isoform X1
uncharacterized protein LOC124428893 isoform X2
uncharacterized LOC124428893, transcript variant X3
uncharacterized protein LOC124428893 isoform X3
laminin subunit alpha-2, transcript variant X1
laminin subunit alpha-2, transcript variant X2
uncharacterized LOC124428781, transcript variant X2
uncharacterized LOC124428781, transcript variant X1
laminin subunit alpha-2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
programmed cell death 6-interacting protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
small ubiquitin-related modifier-like, transcript variant X2
small ubiquitin-related modifier-like, transcript variant X1
single-stranded DNA-binding protein, mitochondrial
pickpocket protein 11, transcript variant X1
pickpocket protein 11, transcript variant X2
mediator of RNA polymerase II transcription subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 1 isoform X1
mediator of RNA polymerase II transcription subunit 1, transcript variant X2
mediator of RNA polymerase II transcription subunit 1 isoform X2
phosphoribosylformylglycinamidine synthase, transcript variant X2
phosphoribosylformylglycinamidine synthase, transcript variant X1
phosphoribosylformylglycinamidine synthase, transcript variant X3
phosphoribosylformylglycinamidine synthase isoform X1
phosphoribosylformylglycinamidine synthase isoform X2
alpha-N-acetylgalactosaminidase, transcript variant X2
alpha-N-acetylgalactosaminidase, transcript variant X1
alpha-N-acetylgalactosaminidase, transcript variant X5
alpha-N-acetylgalactosaminidase, transcript variant X6
alpha-N-acetylgalactosaminidase, transcript variant X4
alpha-N-acetylgalactosaminidase, transcript variant X3
BTB/POZ domain-containing protein 9, transcript variant X1
BTB/POZ domain-containing protein 9, transcript variant X2
2',5'-phosphodiesterase 12, transcript variant X2
2',5'-phosphodiesterase 12, transcript variant X3
2',5'-phosphodiesterase 12, transcript variant X1
uncharacterized LOC124428840, transcript variant X1
uncharacterized LOC124428840, transcript variant X2
uncharacterized LOC124428840, transcript variant X3
phospholipase B1, membrane-associated-like
S-adenosylmethionine synthase, transcript variant X1
S-adenosylmethionine synthase, transcript variant X2
S-adenosylmethionine synthase isoform X1
S-adenosylmethionine synthase isoform X2
alpha-protein kinase 1-like, transcript variant X3
alpha-protein kinase 1-like, transcript variant X1
alpha-protein kinase 1-like, transcript variant X4
alpha-protein kinase 1-like, transcript variant X2
probable global transcription activator SNF2L2 isoform X2
alpha-protein kinase 1-like, transcript variant X6
alpha-protein kinase 1-like, transcript variant X5
probable global transcription activator SNF2L2 isoform X3
probable E3 ubiquitin-protein ligase HERC4, transcript variant X2
probable E3 ubiquitin-protein ligase HERC4, transcript variant X6
probable E3 ubiquitin-protein ligase HERC4, transcript variant X3
probable E3 ubiquitin-protein ligase HERC4, transcript variant X5
probable E3 ubiquitin-protein ligase HERC4, transcript variant X1
probable E3 ubiquitin-protein ligase HERC4, transcript variant X7
probable E3 ubiquitin-protein ligase HERC4, transcript variant X4
probable E3 ubiquitin-protein ligase HERC4 isoform X2
probable E3 ubiquitin-protein ligase HERC4 isoform X3
probable E3 ubiquitin-protein ligase HERC4 isoform X5
probable E3 ubiquitin-protein ligase HERC4 isoform X1
probable E3 ubiquitin-protein ligase HERC4 isoform X4
probable E3 ubiquitin-protein ligase HERC4 isoform X6
probable E3 ubiquitin-protein ligase HERC4 isoform X7
moesin/ezrin/radixin homolog 1, transcript variant X3
moesin/ezrin/radixin homolog 1, transcript variant X8
moesin/ezrin/radixin homolog 1, transcript variant X4
moesin/ezrin/radixin homolog 1, transcript variant X5
moesin/ezrin/radixin homolog 1 isoform X3
moesin/ezrin/radixin homolog 1 isoform X6
moesin/ezrin/radixin homolog 1, transcript variant X1
moesin/ezrin/radixin homolog 1, transcript variant X6
moesin/ezrin/radixin homolog 1, transcript variant X7
moesin/ezrin/radixin homolog 1 isoform X1
moesin/ezrin/radixin homolog 1 isoform X4
moesin/ezrin/radixin homolog 1 isoform X5
moesin/ezrin/radixin homolog 1, transcript variant X9
moesin/ezrin/radixin homolog 1, transcript variant X2
moesin/ezrin/radixin homolog 1 isoform X7
moesin/ezrin/radixin homolog 1 isoform X2
mitogen-activated protein kinase kinase kinase 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 4, transcript variant X3
mitogen-activated protein kinase kinase kinase 4, transcript variant X4
mitogen-activated protein kinase kinase kinase 4, transcript variant X2
mitogen-activated protein kinase kinase kinase 4, transcript variant X1
mitogen-activated protein kinase kinase kinase 4 isoform X1
mitogen-activated protein kinase kinase kinase 4 isoform X2
mitogen-activated protein kinase kinase kinase 4 isoform X3
mitogen-activated protein kinase kinase kinase 4 isoform X4
vesicular acetylcholine transporter, transcript variant X2
vesicular acetylcholine transporter, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
vesicular acetylcholine transporter, transcript variant X3
vesicular acetylcholine transporter isoform X3
high-affinity choline transporter 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
high-affinity choline transporter 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
high-affinity choline transporter 1, transcript variant X1
high-affinity choline transporter 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
RNA-binding protein squid, transcript variant X2
RNA-binding protein squid, transcript variant X3
RNA-binding protein squid, transcript variant X1
RNA-binding protein squid, transcript variant X4
RNA-binding protein squid, transcript variant X7
RNA-binding protein squid, transcript variant X6
RNA-binding protein squid, transcript variant X8
RNA-binding protein squid, transcript variant X5
ras GTPase-activating protein-binding protein 2, transcript variant X1
ras GTPase-activating protein-binding protein 2, transcript variant X2
ras GTPase-activating protein-binding protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
TATA-binding protein-associated factor 172
alkyldihydroxyacetonephosphate synthase, transcript variant X2
alkyldihydroxyacetonephosphate synthase, transcript variant X1
alkyldihydroxyacetonephosphate synthase isoform X1
alkyldihydroxyacetonephosphate synthase isoform X2
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X1
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X2
sodium- and chloride-dependent GABA transporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein KIAA2013 homolog
metabotropic glutamate receptor 7-like, transcript variant X6
metabotropic glutamate receptor 7-like, transcript variant X7
metabotropic glutamate receptor 7-like, transcript variant X8
metabotropic glutamate receptor 7-like, transcript variant X3
metabotropic glutamate receptor 7-like, transcript variant X5
metabotropic glutamate receptor 7-like, transcript variant X4
metabotropic glutamate receptor 7-like, transcript variant X9
metabotropic glutamate receptor 7-like, transcript variant X12
metabotropic glutamate receptor 7-like, transcript variant X11
metabotropic glutamate receptor 7-like, transcript variant X10
metabotropic glutamate receptor 7-like, transcript variant X2
metabotropic glutamate receptor 7-like, transcript variant X1
metabotropic glutamate receptor 7-like isoform X2
metabotropic glutamate receptor 7-like isoform X3
metabotropic glutamate receptor 7-like isoform X1
metabotropic glutamate receptor 7-like isoform X4
dnaJ homolog subfamily C member 5-like, transcript variant X1
dnaJ homolog subfamily C member 5-like, transcript variant X2
dnaJ homolog subfamily C member 5-like isoform X1
dnaJ homolog subfamily C member 5-like isoform X2
uncharacterized LOC124428873, transcript variant X2
uncharacterized LOC124428873, transcript variant X4
uncharacterized LOC124428873, transcript variant X3
uncharacterized LOC124428873, transcript variant X1
uncharacterized LOC124428873, transcript variant X5
uncharacterized LOC124428873, transcript variant X6
protein decapentaplegic-like, transcript variant X2
protein decapentaplegic-like, transcript variant X1
homeobox protein Nkx-2.2a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
homeobox protein Nkx-2.2a-like isoform X2
homeobox protein Nkx-2.2a-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
homeobox protein Nkx-2.2a-like isoform X1
uncharacterized LOC124428696, transcript variant X1
uncharacterized LOC124428696, transcript variant X3
uncharacterized LOC124428696, transcript variant X2
uncharacterized protein LOC124428696 isoform X2
uncharacterized protein LOC124428696 isoform X1
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X3
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X4
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X2
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X1
serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform X2
serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform X1
serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform X3
mortality factor 4-like protein 1, transcript variant X2
mortality factor 4-like protein 1, transcript variant X1
mortality factor 4-like protein 1, transcript variant X3
mortality factor 4-like protein 1 isoform X1
mortality factor 4-like protein 1 isoform X2
alkylated DNA repair protein alkB homolog 8-like, transcript variant X2
alkylated DNA repair protein alkB homolog 8-like, transcript variant X1
alkylated DNA repair protein alkB homolog 8-like isoform X1
alkylated DNA repair protein alkB homolog 8-like isoform X2
serine-rich adhesin for platelets, transcript variant X5
serine-rich adhesin for platelets, transcript variant X1
serine-rich adhesin for platelets, transcript variant X3
serine-rich adhesin for platelets, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine-rich adhesin for platelets, transcript variant X7
serine-rich adhesin for platelets isoform X1
serine-rich adhesin for platelets isoform X3
serine-rich adhesin for platelets isoform X5
serine-rich adhesin for platelets isoform X6
serine-rich adhesin for platelets, transcript variant X4
serine-rich adhesin for platelets, transcript variant X2
serine-rich adhesin for platelets isoform X2
serine-rich adhesin for platelets isoform X4
ubiquitin carboxyl-terminal hydrolase 46
WW domain-containing oxidoreductase-like
39S ribosomal protein L15, mitochondrial
CD109 antigen-like, transcript variant X2
CD109 antigen-like, transcript variant X1
CD109 antigen-like, transcript variant X3
apoptotic chromatin condensation inducer in the nucleus, transcript variant X1
apoptotic chromatin condensation inducer in the nucleus, transcript variant X2
apoptotic chromatin condensation inducer in the nucleus, transcript variant X3
apoptotic chromatin condensation inducer in the nucleus isoform X1
apoptotic chromatin condensation inducer in the nucleus isoform X2
transmembrane 9 superfamily member 2, transcript variant X2
transmembrane 9 superfamily member 2, transcript variant X1
transmembrane 9 superfamily member 2 isoform X2
transmembrane 9 superfamily member 2 isoform X1
transmembrane protein 231-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 231-like, transcript variant X1
transmembrane protein 231-like isoform X2
transmembrane protein 231-like isoform X1
transmembrane protein 231-like, transcript variant X3
transmembrane protein 231-like isoform X3
ubiquitin-conjugating enzyme E2Q-like protein CG4502, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2Q-like protein CG4502, transcript variant X1
ubiquitin-conjugating enzyme E2Q-like protein CG4502
Y+L amino acid transporter 2, transcript variant X1
Y+L amino acid transporter 2, transcript variant X3
large neutral amino acids transporter small subunit 1 isoform X2
Y+L amino acid transporter 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
rab3 GTPase-activating protein catalytic subunit, transcript variant X3
rab3 GTPase-activating protein catalytic subunit, transcript variant X1
rab3 GTPase-activating protein catalytic subunit, transcript variant X2
rab3 GTPase-activating protein catalytic subunit, transcript variant X4
rab3 GTPase-activating protein catalytic subunit isoform X1
rab3 GTPase-activating protein catalytic subunit isoform X2
uncharacterized LOC124428574, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124428574, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transport and Golgi organization protein 6 homolog
eukaryotic translation initiation factor 2-alpha kinase 1-like, transcript variant X2
eukaryotic translation initiation factor 2-alpha kinase 1-like, transcript variant X1
eukaryotic translation initiation factor 2-alpha kinase 1-like, transcript variant X3
eukaryotic translation initiation factor 2-alpha kinase 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
2-oxoglutarate and iron-dependent oxygenase JMJD4-like, transcript variant X4
2-oxoglutarate and iron-dependent oxygenase JMJD4-like, transcript variant X1
2-oxoglutarate and iron-dependent oxygenase JMJD4-like, transcript variant X2
2-oxoglutarate and iron-dependent oxygenase JMJD4-like, transcript variant X3
2-oxoglutarate and iron-dependent oxygenase JMJD4-like isoform X4
2-oxoglutarate and iron-dependent oxygenase JMJD4-like isoform X1
2-oxoglutarate and iron-dependent oxygenase JMJD4-like isoform X2
2-oxoglutarate and iron-dependent oxygenase JMJD4-like isoform X3
2-oxoglutarate and iron-dependent oxygenase JMJD4-like, transcript variant X6
uncharacterized protein LOC124428568 isoform X6
uncharacterized LOC124428571, transcript variant X2
uncharacterized LOC124428571, transcript variant X1
2-oxoglutarate and iron-dependent oxygenase JMJD4-like, transcript variant X5
uncharacterized protein LOC124428568 isoform X5
golgin subfamily A member 4, transcript variant X3
golgin subfamily A member 4, transcript variant X2
golgin subfamily A member 4, transcript variant X1
visual system homeobox 2-like, transcript variant X6
visual system homeobox 2-like, transcript variant X4
visual system homeobox 2-like, transcript variant X1
visual system homeobox 2-like, transcript variant X3
visual system homeobox 2-like, transcript variant X7
visual system homeobox 2-like, transcript variant X5
visual system homeobox 2-like, transcript variant X2
visual system homeobox 2-like isoform X1
visual system homeobox 2-like isoform X5
visual system homeobox 2-like isoform X2
visual system homeobox 2-like isoform X6
visual system homeobox 2-like isoform X3
visual system homeobox 2-like isoform X4
dopamine receptor 2, transcript variant X17
dopamine receptor 2, transcript variant X15
dopamine receptor 2, transcript variant X14
dopamine receptor 2, transcript variant X12
dopamine receptor 2, transcript variant X13
dopamine receptor 2, transcript variant X11
dopamine receptor 2, transcript variant X10
dopamine receptor 2, transcript variant X8
dopamine receptor 2, transcript variant X9
dopamine receptor 2, transcript variant X6
dopamine receptor 2, transcript variant X5
dopamine receptor 2, transcript variant X2
dopamine receptor 2, transcript variant X7
dopamine receptor 2, transcript variant X4
dopamine receptor 2, transcript variant X3
dopamine receptor 2, transcript variant X1
dopamine receptor 2, transcript variant X16
dopamine receptor 2, transcript variant X18
dopamine receptor 2, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
dopamine receptor 2, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
dopamine receptor 2, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
hemolymph lipopolysaccharide-binding protein-like
general odorant-binding protein 56d-like
double-stranded RNA-specific editase Adar, transcript variant X1
double-stranded RNA-specific editase Adar isoform X1
double-stranded RNA-specific editase Adar, transcript variant X2
double-stranded RNA-specific editase Adar, transcript variant X3
double-stranded RNA-specific editase Adar isoform X2
major facilitator superfamily domain-containing protein 6, transcript variant X2
major facilitator superfamily domain-containing protein 6, transcript variant X1
major facilitator superfamily domain-containing protein 6 isoform X1
major facilitator superfamily domain-containing protein 6 isoform X2
uncharacterized LOC124428658, transcript variant X1
uncharacterized LOC124428658, transcript variant X8
uncharacterized LOC124428658, transcript variant X4
uncharacterized LOC124428658, transcript variant X6
uncharacterized LOC124428658, transcript variant X5
uncharacterized LOC124428658, transcript variant X3
uncharacterized LOC124428658, transcript variant X2
uncharacterized LOC124428658, transcript variant X7
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X3
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X1
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X2
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X4
mushroom body large-type Kenyon cell-specific protein 1 isoform X1
mushroom body large-type Kenyon cell-specific protein 1 isoform X2
mushroom body large-type Kenyon cell-specific protein 1 isoform X4
mushroom body large-type Kenyon cell-specific protein 1 isoform X3
ADP-ribosylation factor-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ADP-ribosylation factor-like protein 3, transcript variant X1
ADP-ribosylation factor-like protein 3 isoform X1
ADP-ribosylation factor-like protein 3 isoform X2
uncharacterized LOC124428588, transcript variant X1
uncharacterized LOC124428588, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
peroxisomal N(1)-acetyl-spermine/spermidine oxidase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tyrosine aminotransferase, transcript variant X3
tyrosine aminotransferase, transcript variant X2
tyrosine aminotransferase, transcript variant X1
nuclear receptor coactivator 2-like, transcript variant X10
nuclear receptor coactivator 2-like, transcript variant X4
nuclear receptor coactivator 2-like, transcript variant X5
nuclear receptor coactivator 2-like, transcript variant X9
nuclear receptor coactivator 2-like, transcript variant X1
nuclear receptor coactivator 2-like, transcript variant X2
nuclear receptor coactivator 2-like, transcript variant X3
nuclear receptor coactivator 2-like, transcript variant X11
nuclear receptor coactivator 2-like, transcript variant X8
nuclear receptor coactivator 2-like, transcript variant X7
nuclear receptor coactivator 2-like, transcript variant X6
nuclear receptor coactivator 1-like isoform X7
nuclear receptor coactivator 2-like isoform X2
nuclear receptor coactivator 2-like isoform X3
nuclear receptor coactivator 2-like isoform X6
nuclear receptor coactivator 2-like isoform X1
nuclear receptor coactivator 2-like isoform X4
nuclear receptor coactivator 2-like isoform X5
uncharacterized LOC124428546, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC124428546, transcript variant X6
uncharacterized LOC124428546, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC124428546, transcript variant X3
uncharacterized protein LOC124428546 isoform X5
uncharacterized protein LOC124428546 isoform X3
uncharacterized protein LOC124428546 isoform X4
uncharacterized LOC124428546, transcript variant X1
uncharacterized LOC124428546, transcript variant X2
uncharacterized protein LOC124428546 isoform X1
uncharacterized protein LOC124428546 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ankyrin repeat domain-containing protein 39-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 363 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
piggyBac transposable element-derived protein 4-like, transcript variant X2
piggyBac transposable element-derived protein 4-like, transcript variant X1
piggyBac transposable element-derived protein 4-like isoform X1
piggyBac transposable element-derived protein 4-like isoform X2
probable small nuclear ribonucleoprotein G
uncharacterized LOC124428538, transcript variant X1
uncharacterized LOC124428538, transcript variant X2
uncharacterized protein LOC124428538 isoform X1
uncharacterized protein LOC124428538 isoform X2
epsilon-sarcoglycan, transcript variant X2
epsilon-sarcoglycan, transcript variant X1
epsilon-sarcoglycan, transcript variant X5
epsilon-sarcoglycan, transcript variant X4
epsilon-sarcoglycan, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
epsilon-sarcoglycan, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
epsilon-sarcoglycan, transcript variant X3
vesicular integral-membrane protein VIP36
PPP2R1A-PPP2R2A-interacting phosphatase regulator 1
adenomatous polyposis coli protein-like, transcript variant X1
adenomatous polyposis coli protein-like, transcript variant X2
adenomatous polyposis coli protein-like isoform X2
adenomatous polyposis coli protein-like isoform X1
zinc finger protein 423 homolog, transcript variant X1
zinc finger protein 423 homolog isoform X1
zinc finger protein 423 homolog, transcript variant X3
zinc finger protein 423 homolog, transcript variant X4
zinc finger protein 423 homolog isoform X3
zinc finger protein 423 homolog, transcript variant X2
zinc finger protein 423 homolog isoform X2
solute carrier family 12 member 9, transcript variant X1
solute carrier family 12 member 9, transcript variant X2
transcription factor IIIB 90 kDa subunit, transcript variant X6
transcription factor IIIB 90 kDa subunit, transcript variant X3
transcription factor IIIB 90 kDa subunit, transcript variant X4
transcription factor IIIB 90 kDa subunit, transcript variant X2
transcription factor IIIB 90 kDa subunit, transcript variant X5
transcription factor IIIB 90 kDa subunit, transcript variant X1
transcription factor IIIB 90 kDa subunit, transcript variant X7
transcription factor IIIB 90 kDa subunit
BTB/POZ domain-containing protein 6-B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
BTB/POZ domain-containing protein 6-B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
BTB/POZ domain-containing protein 6-B isoform X1
BTB/POZ domain-containing protein 6-B isoform X2
RNA-binding protein 4.1-like, transcript variant X2
RNA-binding protein 4.1-like, transcript variant X3
RNA-binding protein 4.1-like, transcript variant X5
RNA-binding protein 4.1-like, transcript variant X6
RNA-binding protein 4.1-like, transcript variant X1
RNA-binding protein 4.1-like, transcript variant X4
RNA-binding protein 4.1-like, transcript variant X7
glycine-rich cell wall structural protein 1.8-like isoform X1
glycine-rich cell wall structural protein 1.8-like isoform X7
ubiquitin-like modifier-activating enzyme 5, transcript variant X2
ubiquitin-like modifier-activating enzyme 5, transcript variant X1
ubiquitin-like modifier-activating enzyme 5, transcript variant X4
ubiquitin-like modifier-activating enzyme 5 isoform X2
ubiquitin-like modifier-activating enzyme 5 isoform X1
ubiquitin-like modifier-activating enzyme 5 isoform X4
ubiquitin-like modifier-activating enzyme 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ubiquitin-like modifier-activating enzyme 5 isoform X3
uncharacterized LOC124428827, transcript variant X1
uncharacterized LOC124428827, transcript variant X3
uncharacterized LOC124428827, transcript variant X2
uncharacterized protein LOC124428827 isoform X1
uncharacterized protein LOC124428827 isoform X3
uncharacterized protein LOC124428827 isoform X2
uncharacterized LOC124428821, transcript variant X2
uncharacterized LOC124428821, transcript variant X1
nucleic acid dioxygenase ALKBH1, transcript variant X4
nucleic acid dioxygenase ALKBH1, transcript variant X3
nucleic acid dioxygenase ALKBH1, transcript variant X1
nucleic acid dioxygenase ALKBH1, transcript variant X2
nucleic acid dioxygenase ALKBH1 isoform X3
nucleic acid dioxygenase ALKBH1 isoform X2
nucleic acid dioxygenase ALKBH1 isoform X1
activating transcription factor 3, transcript variant X1
activating transcription factor 3, transcript variant X2
activating transcription factor 3, transcript variant X3
protein transport protein Sec61 subunit gamma
serine/threonine/tyrosine-interacting protein-like
uncharacterized LOC124428599, transcript variant X3
uncharacterized LOC124428599, transcript variant X2
uncharacterized LOC124428599, transcript variant X1
uncharacterized protein LOC124428599 isoform X3
uncharacterized protein LOC124428599 isoform X2
uncharacterized protein LOC124428599 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclin-dependent kinase inhibitor 1C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
organic solute transporter alpha-like protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
disheveled-associated activator of morphogenesis 1, transcript variant X3
disheveled-associated activator of morphogenesis 1 isoform X3
disheveled-associated activator of morphogenesis 1, transcript variant X2
disheveled-associated activator of morphogenesis 1 isoform X2
disheveled-associated activator of morphogenesis 1, transcript variant X1
disheveled-associated activator of morphogenesis 1 isoform X1
uncharacterized LOC124428580, transcript variant X2
uncharacterized LOC124428580, transcript variant X1
39S ribosomal protein L30, mitochondrial, transcript variant X3
39S ribosomal protein L30, mitochondrial, transcript variant X1
39S ribosomal protein L30, mitochondrial, transcript variant X2
39S ribosomal protein L30, mitochondrial
uncharacterized LOC124428699, transcript variant X3
uncharacterized LOC124428699, transcript variant X2
uncharacterized LOC124428699, transcript variant X1
uncharacterized protein LOC124428699 isoform X2
uncharacterized protein LOC124428699 isoform X1
uncharacterized protein LOC124428699 isoform X3
uncharacterized LOC124428699, transcript variant X4
uncharacterized protein LOC124428699 isoform X4
uncharacterized LOC124428699, transcript variant X5
uncharacterized protein LOC124428699 isoform X5
paired mesoderm homeobox protein 1-like, transcript variant X1
paired mesoderm homeobox protein 1-like, transcript variant X2
paired mesoderm homeobox protein 1-like isoform X1
retinal homeobox protein Rx2-like isoform X2
dual specificity protein phosphatase MPK-4-like, transcript variant X2
dual specificity protein phosphatase MPK-4-like, transcript variant X1
dual specificity protein phosphatase MPK-4-like
probable serine/threonine-protein kinase mps1, transcript variant X2
probable serine/threonine-protein kinase mps1, transcript variant X1
probable serine/threonine-protein kinase mps1
casein kinase II subunit beta, transcript variant X2
casein kinase II subunit beta, transcript variant X1
casein kinase II subunit beta, transcript variant X4
casein kinase II subunit beta, transcript variant X3
casein kinase II subunit beta, transcript variant X6
casein kinase II subunit beta, transcript variant X7
casein kinase II subunit beta, transcript variant X8
casein kinase II subunit beta, transcript variant X5
casein kinase II subunit beta isoform X3
casein kinase II subunit beta isoform X1
casein kinase II subunit beta isoform X2
casein kinase II subunit beta isoform X5
casein kinase II subunit beta isoform X4
probable low affinity copper uptake protein 2, transcript variant X1
probable low affinity copper uptake protein 2, transcript variant X2
probable low affinity copper uptake protein 2, transcript variant X3
probable low affinity copper uptake protein 2, transcript variant X4
probable low affinity copper uptake protein 2 isoform X1
probable low affinity copper uptake protein 2 isoform X2
probable low affinity copper uptake protein 2 isoform X3
probable low affinity copper uptake protein 2 isoform X4
endoplasmic reticulum chaperone BiP, transcript variant X2
endoplasmic reticulum chaperone BiP isoform X2
endoplasmic reticulum chaperone BiP, transcript variant X1
endoplasmic reticulum chaperone BiP isoform X1
60 kDa SS-A/Ro ribonucleoprotein-like, transcript variant X1
60 kDa SS-A/Ro ribonucleoprotein-like, transcript variant X2
uncharacterized LOC124428718, transcript variant X1
uncharacterized LOC124428718, transcript variant X3
uncharacterized LOC124428718, transcript variant X2
tetratricopeptide repeat protein 27, transcript variant X1
tetratricopeptide repeat protein 27, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tetratricopeptide repeat protein 27, transcript variant X3
carbonic anhydrase-like, transcript variant X2
carbonic anhydrase-like, transcript variant X1
carbonic anhydrase-like, transcript variant X3
serine/threonine-protein kinase 11-interacting protein, transcript variant X2
serine/threonine-protein kinase 11-interacting protein, transcript variant X6
serine/threonine-protein kinase 11-interacting protein, transcript variant X4
serine/threonine-protein kinase 11-interacting protein, transcript variant X5
serine/threonine-protein kinase 11-interacting protein, transcript variant X1
serine/threonine-protein kinase 11-interacting protein, transcript variant X3
serine/threonine-protein kinase 11-interacting protein isoform X4
uncharacterized protein LOC124428534 isoform X2
uncharacterized protein LOC124428534 isoform X1
uncharacterized protein LOC124428534 isoform X3
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X1
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X2
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X3
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X4
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X5
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X1
calcium-binding mitochondrial carrier protein SCaMC-2-B isoform X2
calcium-binding mitochondrial carrier protein SCaMC-2-A isoform X3
calcium-binding mitochondrial carrier protein SCaMC-2-A isoform X4
endoplasmic reticulum metallopeptidase 1-like, transcript variant X3
endoplasmic reticulum metallopeptidase 1-like, transcript variant X1
endoplasmic reticulum metallopeptidase 1-like, transcript variant X4
endoplasmic reticulum metallopeptidase 1-like, transcript variant X2
endoplasmic reticulum metallopeptidase 1-like, transcript variant X5
endoplasmic reticulum metallopeptidase 1-like isoform X2
endoplasmic reticulum metallopeptidase 1-like isoform X1
endoplasmic reticulum metallopeptidase 1-like isoform X3
endoplasmic reticulum metallopeptidase 1-like isoform X4
26S proteasome complex subunit SEM1, transcript variant X2
26S proteasome complex subunit SEM1, transcript variant X1
neurogenic differentiation factor 1-like
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
solute carrier family 25 member 44, transcript variant X8
solute carrier family 25 member 44, transcript variant X2
solute carrier family 25 member 44, transcript variant X4
solute carrier family 25 member 44, transcript variant X1
solute carrier family 25 member 44, transcript variant X3
solute carrier family 25 member 44, transcript variant X5
solute carrier family 25 member 44, transcript variant X6
solute carrier family 25 member 44, transcript variant X7
solute carrier family 25 member 44 isoform X2
solute carrier family 25 member 44 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01960
COORDINATES: nucleotide motif:Rfam:12.0:RF00002
COORDINATES: nucleotide motif:Rfam:12.0:RF02543
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124428629, transcript variant X2
uncharacterized LOC124428629, transcript variant X3
uncharacterized LOC124428629, transcript variant X1
uncharacterized LOC124428627, transcript variant X2
uncharacterized LOC124428627, transcript variant X3
uncharacterized LOC124428627, transcript variant X1
uncharacterized LOC124428627, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 10% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124428844, transcript variant X3
uncharacterized LOC124428844, transcript variant X2
uncharacterized LOC124428844, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124428601, transcript variant X3
uncharacterized LOC124428601, transcript variant X4
uncharacterized LOC124428601, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC124428601, transcript variant X1
uncharacterized LOC124428600, transcript variant X3
uncharacterized LOC124428600, transcript variant X2
uncharacterized LOC124428600, transcript variant X4
uncharacterized LOC124428600, transcript variant X1
uncharacterized LOC124428623, transcript variant X1
uncharacterized LOC124428623, transcript variant X2
uncharacterized LOC124428529, transcript variant X2
uncharacterized LOC124428529, transcript variant X1
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 18% coverage of the annotated genomic feature by RNAseq alignments
piggyBac transposable element-derived protein 3-like
uncharacterized LOC124428734, transcript variant X1
uncharacterized LOC124428734, transcript variant X3
uncharacterized LOC124428734, transcript variant X2
uncharacterized LOC124428748, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124428748 isoform X3
uncharacterized LOC124428748, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124428748, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC124428748 isoform X1
uncharacterized protein LOC124428748 isoform X2
uncharacterized LOC124428676, transcript variant X1
uncharacterized LOC124428676, transcript variant X2
uncharacterized LOC124428676, transcript variant X3